Search Results - "Borgquist, Signe"

Adjuvant treatment with tamoxifen for estrogen receptor-positive breast cancer and gynecological risks in premenopausal and perimenopausal women – a systematic review.

Authors: Plougmann Gislinge, Julie Isabelle Rubeck Petersen, Kresten Borgquist, Signe et al.

Source: Climacteric. Dec2025, Vol. 28 Issue 6, p657-665. 9p.

HbA1c levels and breast cancer prognosis in women without diabetes.

Authors: Holm, Jonas Busk Bruun, Jens Meldgaard Christiansen, Peer et al.

Source: BMC Cancer. 4/28/2025, Vol. 25 Issue 1, p1-11. 11p.

Feasibility of an exercise program in endocrine-treated metastatic breast cancer patients with overweight: protocol for the FEMA study.

Authors: Wissing, May Skovlund, Pernille Drysdale, Susanne et al.

Source: Pilot & Feasibility Studies. 4/2/2025, Vol. 11 Issue 1, p1-13. 13p.

Dynamic whole-body [¹⁸F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer.

Authors: Pedersen, Mette A. Munk, Ole L. Dias, André H. et al.

Source: EJNMMI Research. 3/4/2024, Vol. 14 Issue 1, p1-12. 12p.

Road traffic noise and breast cancer: DNA methylation in four core circadian genes.

Authors: Thacher, Jesse D. Snigireva, Anastasiia Dauter, Ulrike Maria et al.

Source: Clinical Epigenetics. 11/25/2024, Vol. 16 Issue 1, p1-11. 11p.

Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [¹⁸F]FDG PET/CT.

Authors: Pedersen, Mette Abildgaard Dias, André H. Hjorthaug, Karin et al.

Source: EJNMMI Research. 3/25/2024, Vol. 14 Issue 1, p1-10. 10p.

Statin use and breast cancer survival - a Swedish nationwide study.

Authors: Borgquist, Signe Broberg, Per Tojjar, Jasaman et al.

Source: BMC Cancer. 1/11/2019, Vol. 19 Issue 1, p1-9. 9p. 1 Diagram, 4 Charts.

Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study.

Authors: Kjærgaard, Kasper Aalbæk Harborg, Sixten Jensen, Henrik Kjærulf et al.

Source: Lipids in Health & Disease. 7/2/2022, Vol. 21 Issue 1, p1-7. 7p.

The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients.

Authors: Skarping, Ida Blaabjerg Pedersen, Stine Förnvik, Daniel et al.

Source: Acta Oncologica. Jun2022, Vol. 61 Issue 6, p731-737. 7p. 2 Diagrams, 1 Chart.

Aquaporin‐5 in breast cancer.

Authors: Bystrup, Malte Login, Frédéric H. Edamana, Sarannya et al.

Source: APMIS. May2022, Vol. 130 Issue 5, p253-260. 8p.

Aquaporin‐1 in breast cancer.

Authors: Traberg‐Nyborg, Laura Login, Frédéric H. Edamana, Sarannya et al.

Source: APMIS. Jan2022, Vol. 130 Issue 1, p3-10. 8p.

Aquaporins in pancreatic ductal adenocarcinoma.

Authors: Bruun‐Sørensen, Anne Sofie Edamana, Sarannya Login, Frédéric H. et al.

Source: APMIS. Dec2021, Vol. 129 Issue 12, p700-705. 6p.

Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta‐analysis.

Authors: Harborg, Sixten Larsen, Helene Borup Elsgaard, Stine et al.

Source: Journal of Internal Medicine. Mar2025, Vol. 297 Issue 3, p262-275. 14p.

Late effects – the new focus of follow-up.

Authors: Johansen, Christoffer von Heymann, Annika Rafn, Bolette S. et al.

Source: Acta Oncologica. Oct2022, Vol. 61 Issue 10, p1163-1164. 2p.

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

Authors: Borgquist, Signe Zhou, Wenjing Jirström, Karin et al.

Source: BMC Cancer. 2015, Vol. 15 Issue 1, p1-10. 10p. 3 Charts, 3 Graphs.

Breastfeeding in relation to risk of different breast cancer characteristics.

Authors: Butt, Salma Borgquist, Signe Anagnostaki, Lola et al.

Source: BMC Research Notes. 2014, Vol. 7 Issue 1, p1-17. 17p. 1 Diagram, 4 Charts.

Serum Iodine and Breast Cancer Risk: A Prospective Nested Case-Control Study Stratified for Selenium Levels.

Authors: Manjer, Jonas Sandsveden, Malte Borgquist, Signe

Source: Cancer Epidemiology, Biomarkers & Prevention. Jul2020, Vol. 29 Issue 7, p1335-1340.

Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study.

Authors: Skarping, Ida Förnvik, Daniel Heide-Jørgensen, Uffe et al.

Source: Acta Oncologica. Dec2020, Vol. 59 Issue 12, p1528-1537. 10p. 4 Charts, 1 Graph.

Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study.

Authors: Aggerholm-Pedersen, Ninna Jellesmark Thorsen, Lise Bech Tauber, Nina Møller et al.

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p518-525. 8p.

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome.

Authors: Bengtsson, Erik Nerjovaj, Pashtrik Wangefjord, Sakarias et al.

Source: Diagnostic Pathology. 2014, Vol. 9 Issue 1, p1-13. 13p.